A Deep-Learning-Derived Ultrasound Framework for Hepatic Steatosis Detection and Integrated Fibrosis Assessment: A Multicenter Study
Background/Objectives: We aimed to develop an integrated B-mode ultrasound framework for hepatic steatosis detection and fibrosis assessment in patients with suspected metabolic dysfunction-associated steatotic liver disease (MASLD). Methods: This multicenter study prospectively included 734 participants with 2485 ultrasound images from eight centers (April 2023–November 2025). A Global Attention Mechanism-enhanced Cross-Attention Multi-Scale Vision Transformer was used to derive a steatosis signature in Dataset A (Centers 1–3, n = 245), with external testing in Datasets B (Centers 4–5, n = 294) and C (Centers 6–8, n = 195). The signature was then integrated with liver elasticity and clinical and laboratory variables to develop a fibrosis prediction model in Dataset B, with external testing in Dataset C. Results: The steatosis signature achieved AUROCs of 0.887 (95% CI, 0.831–0.938) and 0.968 (95% CI, 0.932–0.994) in Datasets B and C, respectively, significantly outperforming the hepatic steatosis index, fatty liver index, and the junior radiologist (AUROC range: 0.728–0.794; all p < 0.05), while performing comparably to the senior radiologist (AUROC range: 0.864–0.932). The fibrosis model achieved an AUROC of 0.849 (95% CI, 0.762–0.916) in Dataset C and significantly outperformed elasticity, fibrosis-4 index, aspartate aminotransferase-to-platelet ratio index, and nonalcoholic fatty liver disease fibrosis score (AUROC range: 0.431–0.697; all p < 0.05). For F0 versus F1, the model also achieved an AUROC of 0.841 (95% CI, 0.745–0.922), significantly outperforming all comparators (all p < 0.05). Conclusions: This integrated framework provides a noninvasive approach for steatosis case-finding and early fibrosis risk stratification in patients with suspected MASLD.
Authors
- Liyun Xue (ORCID: https://orcid.org/0000-0001-5701-2000)
- Zunguo Du (ORCID: https://orcid.org/0009-0009-1476-8196)
- Wentao Kong (ORCID: https://orcid.org/0000-0002-4313-6958)
- Hong Ding (ORCID: https://orcid.org/0000-0002-9998-0904)
- Xin Li (ORCID: https://orcid.org/0000-0001-5154-2115)
- Jing Liang
- Dong Jiang
- Han Liu
- Yuli Zhu
Institutions
- Jiangsu University (CN)
- Second Military Medical University (CN)
- Fudan University (CN)
- Affiliated Hospital of Jiangsu University (CN)
- Changhai Hospital (CN)
- Zhongshan Hospital (CN)
- Eastern Hepatobiliary Surgery Hospital (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- Biomedicines
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3390/biomedicines14112656
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Huashan Hospital